Zhihong Huang

5 South Zhongguancun Street
Haidian, 100081, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

PTPRG-AS1 regulates the KITLG/KIT pathway through the ceRNA axis to promote the malignant progression of gastric cancer and the intervention effect of Compound Kushen injection on it.

PTPRG-AS1 regulates the KITLG/KIT pathway through the ceRNA axis to promote the malignant progression of gastric cancer and the intervention effect of Compound Kushen injection on it.

Journal: Pharmacological research

Published: March 06, 2025

Beyond interacting with Rap1: Dissecting the roles of Rif1.

Beyond interacting with Rap1: Dissecting the roles of Rif1.

Journal: International journal of biological macromolecules

Published: November 08, 2024

Unraveling the Molecular Mechanisms of SIRT7 in Angiogenesis: Insights from Substrate Clues.

Unraveling the Molecular Mechanisms of SIRT7 in Angiogenesis: Insights from Substrate Clues.

Journal: International journal of molecular sciences

Published: September 19, 2024

Enhancing the detonation performance of azobistriazole energetic derivatives via inducing N-oxide groups.

Enhancing the detonation performance of azobistriazole energetic derivatives via inducing N-oxide groups.

Journal: Physical chemistry chemical physics : PCCP

Published: July 11, 2024

Molecular insights into gastric cancer: The impact of TGFBR2 and hsa-mir-107 revealed by microarray sequencing and bioinformatics.

Molecular insights into gastric cancer: The impact of TGFBR2 and hsa-mir-107 revealed by microarray sequencing and bioinformatics.

Journal: Computers in biology and medicine

Published: November 20, 2023

Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019.

Integrated network pharmacology analysis and in vitro validation revealed the underlying mechanism of Xiyanping injection in treating coronavirus disease 2019.

Journal: Medicine

Published: September 01, 2023

The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.

The anti-hepatocellular carcinoma effect of Aidi injection was related to the synergistic action of cantharidin, formononetin, and isofraxidin through BIRC5, FEN1, and EGFR.

Journal: Journal of ethnopharmacology

Published: August 04, 2023

A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification.

A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification.

Journal: Computers in biology and medicine

Published: July 28, 2023

Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis.

Identification of an immune-related 6-lncRNA panel with a good performance for prognostic prediction in hepatocellular carcinoma by integrated bioinformatics analysis.

Journal: Medicine

Published: July 21, 2023

Correction: Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking.

Correction: Exploring the effect of Yinzhihuang granules on alcoholic liver disease based on pharmacodynamics, network pharmacology and molecular docking.

Journal: Chinese medicine

Published: July 10, 2023

Corrigendum to "Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease" [J. Ethnopharmacol. 310 (2023) 116418].

Corrigendum to "Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease" [J. Ethnopharmacol. 310 (2023) 116418].

Journal: Journal of ethnopharmacology

Published: June 30, 2023

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology.

Journal: Frontiers in pharmacology

Published: June 20, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026